Strategy

Oct 16, 2017
Pharmaceutical Executive
Pamela Buffone from Privacy Analytics discusses growth in the specialty pharma sector and making patient data protection a top priority.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Sep 20, 2017
Pharmaceutical Executive
Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.
Sep 05, 2017
Neil Grubert reviews the UK’s post-Brexit life sciences strategy, with a particular focus on the key area of market access.
Sep 04, 2017
As regulators lower evidentiary requirements for approval to speed development/review of new drugs for unmet medical needs, payers are demanding more data to justify price premiums. How can companies can navigate these complexities?
Aug 25, 2017
Pharmaceutical Executive
Experts assess the current pharma dealmaking landscape—one where, despite market headwinds, is still heavily influenced by factors under the buyer and seller’s control.
Aug 10, 2017
In the first of three blogs on how digital strategy and a “data culture” can help define and deliver value, David Ormesher focuses on Value Creation.
Jul 06, 2017
Big data has proven to be a valuable business asset, but using it to gain competitive advantage requires the right combination of strategy, technology and execution.
Jun 20, 2017
Most challenges boil down to two simple categories: "complicated" and "complex". Knowing how to categorize each problem is key to solving it, writes Steve Figman.
native1_300x100
lorem ipsum